An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing

Asuka Nakarai, Jun Kato, Sakiko Hiraoka, Shiho Takashima, Toshihiro Inokuchi, Masahiro Takahara, Yuusaku Sugihara, Keita Harada, Hiroyuki Okada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background/Aims: Although mucosal healing (MH) has been considered a treatment goal for patients with ulcerative colitis (UC), the risk factors predictive of relapse in patients who achieve MH are unknown. Because the platelet count has been shown to be a marker of inflammation in inflammatory bowel diseases, this study aimed to assess whether the platelet count could predict relapse in UC patients with MH. Methods: A prospective observational study was performed. UC patients with MH were consecutively enrolled in the study and monitored for at least 2 years or until relapse. The correlation between the incidence of relapse and the platelet count at the time of study enrollment was examined. Results: In total, 43 patients were enrolled, and 14 patients (33%) relapsed. The median platelet count at the time of enrollment in the patients who relapsed significantly differed from that in the patients who did not relapse (27.2×104/ µL vs 23.8×104/µL, respectively; p=0.016). A platelet count >25.0×104/µL was a significant risk factor for relapse based on a multivariate analysis (hazard ratio, 4.85; 95% confidence interval, 1.07 to 25.28), and according to the Kaplan-Meier analysis, this cutoff could identify patients susceptible to relapse (p=0.041, log-rank test). Conclusions: The platelet count could be used as a predictor of relapse in UC patients with MH.

Original languageEnglish
Pages (from-to)420-425
Number of pages6
JournalGut and Liver
Volume12
Issue number4
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Platelet Count
Ulcerative Colitis
Recurrence
Time and Motion Studies
Kaplan-Meier Estimate
Inflammatory Bowel Diseases
Observational Studies
Multivariate Analysis
Prospective Studies
Confidence Intervals
Inflammation
Incidence

Keywords

  • Colitis
  • Mucosal healing
  • Platelet count
  • Recurrence
  • Ulcerative

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing. / Nakarai, Asuka; Kato, Jun; Hiraoka, Sakiko; Takashima, Shiho; Inokuchi, Toshihiro; Takahara, Masahiro; Sugihara, Yuusaku; Harada, Keita; Okada, Hiroyuki.

In: Gut and Liver, Vol. 12, No. 4, 01.07.2018, p. 420-425.

Research output: Contribution to journalArticle

Nakarai, Asuka ; Kato, Jun ; Hiraoka, Sakiko ; Takashima, Shiho ; Inokuchi, Toshihiro ; Takahara, Masahiro ; Sugihara, Yuusaku ; Harada, Keita ; Okada, Hiroyuki. / An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing. In: Gut and Liver. 2018 ; Vol. 12, No. 4. pp. 420-425.
@article{a0d799477e9c4a7eac3571c96888d5f3,
title = "An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing",
abstract = "Background/Aims: Although mucosal healing (MH) has been considered a treatment goal for patients with ulcerative colitis (UC), the risk factors predictive of relapse in patients who achieve MH are unknown. Because the platelet count has been shown to be a marker of inflammation in inflammatory bowel diseases, this study aimed to assess whether the platelet count could predict relapse in UC patients with MH. Methods: A prospective observational study was performed. UC patients with MH were consecutively enrolled in the study and monitored for at least 2 years or until relapse. The correlation between the incidence of relapse and the platelet count at the time of study enrollment was examined. Results: In total, 43 patients were enrolled, and 14 patients (33{\%}) relapsed. The median platelet count at the time of enrollment in the patients who relapsed significantly differed from that in the patients who did not relapse (27.2×104/ µL vs 23.8×104/µL, respectively; p=0.016). A platelet count >25.0×104/µL was a significant risk factor for relapse based on a multivariate analysis (hazard ratio, 4.85; 95{\%} confidence interval, 1.07 to 25.28), and according to the Kaplan-Meier analysis, this cutoff could identify patients susceptible to relapse (p=0.041, log-rank test). Conclusions: The platelet count could be used as a predictor of relapse in UC patients with MH.",
keywords = "Colitis, Mucosal healing, Platelet count, Recurrence, Ulcerative",
author = "Asuka Nakarai and Jun Kato and Sakiko Hiraoka and Shiho Takashima and Toshihiro Inokuchi and Masahiro Takahara and Yuusaku Sugihara and Keita Harada and Hiroyuki Okada",
year = "2018",
month = "7",
day = "1",
doi = "10.5009/gnl17236",
language = "English",
volume = "12",
pages = "420--425",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "4",

}

TY - JOUR

T1 - An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing

AU - Nakarai, Asuka

AU - Kato, Jun

AU - Hiraoka, Sakiko

AU - Takashima, Shiho

AU - Inokuchi, Toshihiro

AU - Takahara, Masahiro

AU - Sugihara, Yuusaku

AU - Harada, Keita

AU - Okada, Hiroyuki

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background/Aims: Although mucosal healing (MH) has been considered a treatment goal for patients with ulcerative colitis (UC), the risk factors predictive of relapse in patients who achieve MH are unknown. Because the platelet count has been shown to be a marker of inflammation in inflammatory bowel diseases, this study aimed to assess whether the platelet count could predict relapse in UC patients with MH. Methods: A prospective observational study was performed. UC patients with MH were consecutively enrolled in the study and monitored for at least 2 years or until relapse. The correlation between the incidence of relapse and the platelet count at the time of study enrollment was examined. Results: In total, 43 patients were enrolled, and 14 patients (33%) relapsed. The median platelet count at the time of enrollment in the patients who relapsed significantly differed from that in the patients who did not relapse (27.2×104/ µL vs 23.8×104/µL, respectively; p=0.016). A platelet count >25.0×104/µL was a significant risk factor for relapse based on a multivariate analysis (hazard ratio, 4.85; 95% confidence interval, 1.07 to 25.28), and according to the Kaplan-Meier analysis, this cutoff could identify patients susceptible to relapse (p=0.041, log-rank test). Conclusions: The platelet count could be used as a predictor of relapse in UC patients with MH.

AB - Background/Aims: Although mucosal healing (MH) has been considered a treatment goal for patients with ulcerative colitis (UC), the risk factors predictive of relapse in patients who achieve MH are unknown. Because the platelet count has been shown to be a marker of inflammation in inflammatory bowel diseases, this study aimed to assess whether the platelet count could predict relapse in UC patients with MH. Methods: A prospective observational study was performed. UC patients with MH were consecutively enrolled in the study and monitored for at least 2 years or until relapse. The correlation between the incidence of relapse and the platelet count at the time of study enrollment was examined. Results: In total, 43 patients were enrolled, and 14 patients (33%) relapsed. The median platelet count at the time of enrollment in the patients who relapsed significantly differed from that in the patients who did not relapse (27.2×104/ µL vs 23.8×104/µL, respectively; p=0.016). A platelet count >25.0×104/µL was a significant risk factor for relapse based on a multivariate analysis (hazard ratio, 4.85; 95% confidence interval, 1.07 to 25.28), and according to the Kaplan-Meier analysis, this cutoff could identify patients susceptible to relapse (p=0.041, log-rank test). Conclusions: The platelet count could be used as a predictor of relapse in UC patients with MH.

KW - Colitis

KW - Mucosal healing

KW - Platelet count

KW - Recurrence

KW - Ulcerative

UR - http://www.scopus.com/inward/record.url?scp=85049974849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049974849&partnerID=8YFLogxK

U2 - 10.5009/gnl17236

DO - 10.5009/gnl17236

M3 - Article

C2 - 29945423

AN - SCOPUS:85049974849

VL - 12

SP - 420

EP - 425

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 4

ER -